ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
06 Jul 2020 05:04

Celltrion Pair Trade: Healthcare Being Pushed Out a Little Too Extreme

The Celltrion duo is now at -1.6σ on a 20D MA. It is virtually the widest diversion we see in a month.The current price ratio is 0.35, which is a...

Logo
285 Views
Share
02 Jul 2020 00:03

Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing

Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...

Logo
354 Views
Share
07 Jun 2020 09:58

Asia Short Interest Weekly - Massive Short Increase on Meituan, Geely

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
322 Views
Share
29 May 2020 08:15

Global Emerging Markets:  Unloved Stocks

Many stocks in the benchmark MSCI Emerging Markets index are largely avoided by active investors.  To screen for unloved stocks, we filter our...

Logo
341 Views
Share
27 May 2020 03:25

Celltrion H Block Deal: Terms, Overhang, Arb Yield, & Post-Deal Trade Angle

Terms & overhangHere is another deal by OEP on Celltrion Healthcare. 4M shares are on the table (2.64% of the SO). The seller set the discount...

Logo
311 Views
Share
x